Company news

KORU Medical Systems, Inc. news in 2025

KORU Medical Systems, Inc.'s news releases, calls and decks from 2025, newest first.

View company

KORU Medical Systems Announces 510(k) Submission for Clearance of the FreedomEDGE® System with a Commercialized Oncology Biologic

December 30, 2025

KORU Medical Systems, Inc. Appoints Eric Schiller as Chief Technology Officer

December 16, 2025

KORU Medical Systems to Present Promising Results on the Use of the FreedomEDGE® Syringe Infusion System in Infusion Centers at ESID/EHA/SIOPE Focused Symposium 2025

November 17, 2025

KORU Medical Systems to Participate in Upcoming Investor Conferences

November 13, 2025

KORU Medical Systems Announces 27% Q3 Revenue Growth and Raises 2025 Revenue Guidance

November 12, 2025

KORU Medical Systems Announces Development Agreement for Innovation in Subcutaneous Immunoglobulin Infusion Systems

November 4, 2025

KORU Medical Systems to Report Third Quarter 2025 Financial Results on November 12, 2025

October 22, 2025

ForCast Orthopedics and KORU Medical Systems Announce Agreement for Novel Antibiotic Infusion Therapy

September 18, 2025

Cirtec Medical Announces Appointment of New Chief Executive Officer

August 28, 2025

KORU Medical Systems Announces Q2 2025 Financial Results, Including Record Double-digit Revenue, and Raises 2025 Revenue Guidance

August 6, 2025

KORU Medical Systems to Participate in the Canaccord Genuity 45th Annual Growth Conference

July 30, 2025

KORU Medical Systems to Report Second Quarter 2025 Financial Results on August 6, 2025

July 16, 2025

KORU Medical Systems Appoints Adam Kalbermatten as Chief Commercial Officer

July 7, 2025

KORU Medical Systems to Join Russell 3000® and Russell 2000® Indexes

June 11, 2025

KORU Medical Systems Announces Record Q1 2025 Financial Results and Raises 2025 Revenue Guidance

May 7, 2025

KORU Medical Systems to Report First Quarter 2025 Financial Results on May 7, 2025

April 16, 2025

KORU Medical Systems Announces Fourth Quarter and Full Year 2024 Financial Results With Record Revenues and Gross Profit; Issues Full Year 2025 Guidance

March 12, 2025

KORU Medical Systems to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025

February 19, 2025

KORU Medical Systems Announces Agreement for Next-Generation Subcutaneous Immunoglobulin Infusion System

February 5, 2025

KORU Medical Systems Announces Phase III Clinical Trial Collaboration for a New Drug Indication in Nephrology

January 29, 2025

KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results; Achieves Record Full Year and Quarterly Revenues; Positive Cash Flow for the Fourth Quarter

January 12, 2025

Calls in 2025

Decks in 2025